Anika Therapeutics | ANIK - Ebitda





Ebitda Perubahan Tanggal
Abbott USD 2.43B 844M 2026-03
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -80.97M 93.7M 2026-09
Integra LifeSciences USD 79.79M 1.37M 2026-09
Intrexon USD -24.7M 2.92M 2024-06
J&J USD 8.99B 721M 2026-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
MacroGenics USD -30.2M 52.15M 2026-03
Merit Medical Systems USD 103.93M 461K 2026-09
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Sanofi EUR 3.69B 375M 2026-06
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.83B 102M 2026-09
Veracyte USD 43.96M 1.16M 2026-06
Xencor USD -34.63M 86.74M 2026-06
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06